FABIAN Posters bio
analyse
.org
Home
Agenda
Archief
Netwerk
Nieuws | News
Symposia
Werkgroep

Programma
Abstracts
Posters
Submissie
Slides
Hotels
Route

 

FABIAN 2008

Biopharma, Biosimilar, Biogeneric? Bioanalysis!

6 November 2008, UMCG, Groningen

 

Poster
Abstract

CHARACTERIZATION OF IMPURITIES AND MODIFICATIONS IN PROTEIN PRODUCTS USING LIQUID CHROMATOGRAPHY AND DATA INDEPENDENT ACQUISITION TANDEM MASS SPECTROMETRY
Mike van Oosterhout, Waters Chromatography Etten-leur, NL
Hongwei Xie, Martin Gilar, John C. Gebler Waters Corporation, Milford, MA USA

08P01

AN AUTOMATED LC/MS DATA ANALYSIS USING BIOPHARMALYNX: A CASE STUDY FOR CHARACTERISATION OF THERAPEUTIC INTERFERON PROTEIN
Mike van Oosterhout, Waters Chromatography, Etten-leur, NL
Joomi Ahn, Ying Qing Yu, Martin Gilar, John Gebler Waters Corporation, Milford, MA USA

08P02

CE-ToF-MS systems using non-covalent multi-layer coated capillaries for the analysis of pharmaceutical proteins
Rob Haselberg*, Gerhardus J. de Jong and Govert W. Somsen
Department of Biomedical Analysis, Utrecht University, P.O. Box 80082, 3508 TB Utrecht, the Netherlands

08P03

In vivo microdialysis in rats: LC-MS/MS analysis of microdialysis samples
Brigitte Buscher, Ria Brust-van Schaik, Inge van Schöll, Astrid Capello and Florence Salmon
TNO Quality of life, Utrechtseweg 48, 3700 AJ Zeist, The Netherlands

08P04

NEW APPLICATIONS OF QTRAP® AND TRIPLE QUADRUPOLE SYSTEMS IN PHARMACEUTICAL ANALYSIS
Applied Biosystems|MDS Analytical Technologies

08P05

EMPLOYING HIGHER RESOLUTION TO OBTAIN BETTER SELECTIVITY FOR QUANTITATION EXPERIMENTS ON A TRIPLE- QUADRUPOLE INSTRUMENT PLATFORM (API 5000TM LC/MS SYSTEM)
Anthony J. Romanelli, Jeffrey D. Miller, Xavier J. Misonne,
Applied Biosystems, Framingham, MA, USA

08P06

A HIGHLY AUTOMATED WORKFLOW FOR FAST AND COMPREHENSIVE IDENTIFICATION OF IMPURITIES AND DEGRADATION PRODUCTS IN PHARMACEUTICAL PRODUCTS USING LC/MS/MS.
John Gibbons1, Nicolas Rupcich2 and David Duncan2,
1. Applied Biosystems / MDS Analytical Technologies, Concord, Ontario, Canada,
2. Genpharm Inc., Etobicoke, Ontario, Canada

08P07

HARDWARE AND SOFTWARE DESIGN STRATEGIES FOR THE RAPID DETERMINATION OF OPTIMAL QUANTITATIVE MS/MS CONDITIONS
April L. Smith1; Anthony J. Romanelli1; Elliott Jones1; John Janiszewski2; Hua-fen Liu1; Steve Ainley3; Richard Schneider2; Kevin Shirey3; Eva Duchoslav1; Loren Olson1
1. Applied Biosystems, Framingham, MA and Foster City, CA;
2. Pfizer Inc., Westerly, RI;
3. Sound Analytics, East Lyme, CT

08P08

ACCELERATED LC/MS/MS FOR THE QUANTITATION AND CONFIRMATION OF PESTICIDES IN FOOD AND WATER SAMPLES
André Schreiber1, Doina Caraiman1, Nadia Pace1, Tim Hoffman1, Byron Kieser1 and CJ Baker2
1. Applied Biosystems/MDS Analytical Technologies Concord, ON (Canada),
2. University of Calgary, Calgary, AL (Canada)

08P09

EFFICIENT PEPTIDE PURIFICATION BY HPLC, EFFECT OF PORE SIZE, PARTICLE SIZE AND CHEMISTRY.
Gezinus Grooten
Aurora Borealis Control BV, Schoonebeek, The Netherlands

08P10

YMC-BIOPRO, POROUS AND NONPOROUS IEX COLUMNS.
Gezinus Grooten
Aurora Borealis Control BV, Schoonebeek, The Netherlands

08P11

LAMP-BASED NATIVE FLUORESCENCE DETECTION OF PHARMACEUTICAL PROTEINS IN CAPILLARY ELECTROPHORESIS
B.J. de Kort*, D.Č. Radenović, G.J. De Jong, G.W. Somsen
Department of Biomedical Analysis, Utrecht University, P.O. Box 80082, 3508 TB Utrecht, the Netherlands

08P12

METHOD VALIDATION APPROACH FOR THE DETERMINATION OF ANTIBODY RESPONSE TO BIOPHARMACEUTICALS
Marcel van der Linden, Ole Lagatie, Harry Verdonk and Jan Dankers
Eurofins Medinet B.V., Department of Specialized Biomolecules, Bergschot 71, 4817 PA Breda, The Netherlands

08P13

DEVELOPMENT OF AN AUTOMATED SPR-IMER-LC-MS/MS PLATFORM FOR ISOLATION, QUANTIFICATION AND IDENTIFICATION OF PROTEINS FROM PLASMA
E.C.A. Stigter*, G.J. de Jong, W.P. van Bennekom
Utrecht University, Faculty of Sciences, Department of Pharmaceutical Sciences (Biomedical Analysis), Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands

08P14

ELISA WITH ICP-MS DETECTION AS A SELECTIVE DETECTION TECHNIQUE FOR BIOMARKER ASSAYS
Simone Hof, Monique Putman and Jaap Wieling
Xendo Drug Development Services, P.O. Box 137, 9700 AC, The Netherlands

08P15

STATISTICAL EVALUATION OF THE BENEFIT OF COMBINED USE OF ACCURATE MASS AND ISOTOPIC PATTERN
Marcus Macht1; Petra Decker1; Aiko Barsch1; Ilmari Krebs1 and Rob van der Heijden2
1 Bruker Daltonik, Bremen, Germany
2 Bruker Daltonics BV, Wormer, the Netherlands

08P16

SOFTWARE-SUPPORTED TOP-DOWN PROTEIN SEQUENCE CHARACTERIZATION AND ASSIGNMENT OF TERMINI
Detlev Suckau1, Lars Vorwerg1, Anja Resemann1 and Rob van der Heijden2
1 Bruker Daltonik GmbH, Bremen, Germany
2 Bruker Daltonics BV, Wormer, The Netherlands

08P17

ADVANCES IN THE OPTIMIZATION OF A MICRO-FLOW HPLC (LC-MS) SYSTEM
Rein Reitsma
Separations Analytical Instruments, The Netherlands

08P18

INTEGRATED BIOPHARMACEUTICAL DEVELOPMENT: NEW CHALLENGES TO EXPIDITE THE PROOF-OF-CONCEPT STAGE AND TIME TO MARKET
Izaak den Daas, Johan Wemer, Ineke Jonker, Thijs van Iersel, Ard Tijsterman and Jaap Wieling
Xendo Integrated Biopharmaceutical Development, Hanzeplein 1, Entrance 53, 9713 GZ Groningen, The Netherlands

08P19

(PRE)CLINICAL IMMUNOGENICITY ASSAY DEVELOPMENT
Hans Mocking and Cees Koopal
TNO Quality of Life, Dept. of Analytical Research, Utrechtseweg 48, 3704 HE Zeist, The Netherlands.

08P20

CIEF–MALDI-TOF-MS FOR THE ANALYSIS OF (BIOPHARMACEUTICAL) PROTEINS
L.H.H. Silvertand, J. Sastre Toraño, G.J. de Jong, W.P. van Bennekom
Biomedical Analysis, Pharmaceutical Analysis, University of Utrecht, P.O. Box 80082, 3508 TB Utrecht, The Netherlands

08P21
* Contact

Programma ] Abstracts ] [ Posters ] Submissie ] Slides ] Hotels ] Route ]
2001 ] 2002 ] 2003 ] 2004 ] 2005 ] 2006 ] 2007 ] 2008 ] 2009 ]

Last update
27-Oct-09